Publication | Open Access
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
158
Citations
34
References
2019
Year
ClinicalTrials.gov Identifier: NCT01088815.
| Year | Citations | |
|---|---|---|
Page 1
Page 1